O	0	4	Pten	Pten	NN	B-NP
O	5	14	signaling	signaling	NN	I-NP
O	15	17	in	in	IN	B-PP
B-Cancer	18	25	gliomas	glioma	NNS	B-NP
O	25	26	.	.	.	O

O	27	29	In	In	IN	B-PP
O	30	34	1997	1997	CD	B-NP
O	34	35	,	,	,	O
O	36	39	the	the	DT	B-NP
O	40	44	PTEN	PTEN	NN	I-NP
O	45	49	gene	gene	NN	I-NP
O	50	51	(	(	(	O
O	51	62	phosphatase	phosphatase	NN	B-NP
O	63	66	and	and	CC	O
O	67	73	tensin	tensin	NN	B-NP
O	74	81	homolog	homolog	NN	I-NP
O	82	89	deleted	delete	VBN	B-VP
O	90	92	on	on	IN	B-PP
O	93	103	chromosome	chromosome	NN	B-NP
O	104	106	10	10	CD	I-NP
O	106	107	)	)	)	O
O	108	111	was	be	VBD	B-VP
O	112	122	identified	identify	VBN	I-VP
O	123	125	as	as	IN	B-PP
O	126	127	a	a	DT	B-NP
B-Cancer	128	133	tumor	tumor	NN	I-NP
O	134	144	suppressor	suppressor	NN	I-NP
O	145	149	gene	gene	NN	I-NP
O	150	152	on	on	IN	B-PP
O	153	156	the	the	DT	B-NP
O	157	161	long	long	JJ	I-NP
O	162	165	arm	arm	NN	I-NP
O	166	168	of	of	IN	B-PP
B-Cellular_component	169	179	chromosome	chromosome	NN	B-NP
I-Cellular_component	180	182	10	10	CD	I-NP
O	182	183	.	.	.	O

O	184	189	Since	Since	IN	B-PP
O	190	194	then	then	RB	B-NP
O	194	195	,	,	,	O
O	196	205	important	important	JJ	B-NP
O	206	214	progress	progress	NN	I-NP
O	215	218	has	have	VBZ	B-VP
O	219	223	been	be	VBN	I-VP
O	224	228	made	make	VBN	I-VP
O	229	233	with	with	IN	B-PP
O	234	241	respect	respect	NN	B-NP
O	242	244	to	to	TO	B-PP
O	245	248	the	the	DT	B-NP
O	249	262	understanding	understanding	NN	I-NP
O	263	265	of	of	IN	B-PP
O	266	269	the	the	DT	B-NP
O	270	274	role	role	NN	I-NP
O	275	277	of	of	IN	B-PP
O	278	281	the	the	DT	B-NP
O	282	286	Pten	Pten	NN	I-NP
O	287	294	protein	protein	NN	I-NP
O	295	297	in	in	IN	B-PP
O	298	301	the	the	DT	B-NP
O	302	308	normal	normal	JJ	I-NP
O	309	320	development	development	NN	I-NP
O	321	323	of	of	IN	B-PP
O	324	327	the	the	DT	B-NP
B-Organ	328	333	brain	brain	NN	I-NP
O	334	336	as	as	RB	B-CONJP
O	337	341	well	well	RB	I-CONJP
O	342	344	as	as	IN	I-CONJP
O	345	347	in	in	IN	B-PP
O	348	351	the	the	DT	B-NP
O	352	361	molecular	molecular	JJ	I-NP
O	362	374	pathogenesis	pathogenesis	NN	I-NP
O	375	377	of	of	IN	B-PP
O	378	383	human	human	JJ	B-NP
B-Cancer	384	391	gliomas	glioma	NNS	I-NP
O	391	392	.	.	.	O

O	393	397	This	This	DT	B-NP
O	398	404	review	review	NN	I-NP
O	405	415	summarizes	summarize	VBZ	B-VP
O	416	419	the	the	DT	B-NP
O	420	427	current	current	JJ	I-NP
O	428	433	state	state	NN	I-NP
O	434	436	of	of	IN	B-PP
O	437	440	the	the	DT	B-NP
O	441	444	art	art	NN	I-NP
O	445	455	concerning	concern	VBG	B-VP
O	456	459	the	the	DT	B-NP
O	460	471	involvement	involvement	NN	I-NP
O	472	474	of	of	IN	B-PP
O	475	483	aberrant	aberrant	JJ	B-NP
O	484	488	Pten	Pten	NN	I-NP
O	489	497	function	function	NN	I-NP
O	498	500	in	in	IN	B-PP
O	501	504	the	the	DT	B-NP
O	505	516	development	development	NN	I-NP
O	517	519	of	of	IN	B-PP
O	520	529	different	different	JJ	B-NP
O	530	538	biologic	biologic	JJ	I-NP
O	539	547	features	feature	NNS	I-NP
O	548	550	of	of	IN	B-PP
B-Cancer	551	560	malignant	malignant	JJ	B-NP
I-Cancer	561	568	gliomas	glioma	NNS	I-NP
O	568	569	,	,	,	O
O	570	574	such	such	JJ	B-PP
O	575	577	as	as	IN	I-PP
O	578	582	loss	loss	NN	B-NP
O	583	585	of	of	IN	B-PP
B-Cell	586	590	cell	cell	NN	B-NP
O	590	591	-	-	HYPH	B-NP
O	591	596	cycle	cycle	NN	I-NP
O	597	604	control	control	NN	I-NP
O	605	608	and	and	CC	O
O	609	621	uncontrolled	uncontrolled	JJ	B-NP
B-Cell	622	626	cell	cell	NN	I-NP
O	627	640	proliferation	proliferation	NN	I-NP
O	640	641	,	,	,	O
O	642	648	escape	escape	NN	B-NP
O	649	653	from	from	IN	B-PP
O	654	663	apoptosis	apoptosis	NN	B-NP
O	663	664	,	,	,	O
B-Organ	665	670	brain	brain	NN	B-NP
O	671	679	invasion	invasion	NN	I-NP
O	679	680	,	,	,	O
O	681	684	and	and	CC	O
O	685	693	aberrant	aberrant	JJ	B-NP
O	694	709	neoangiogenesis	neoangiogenesis	NN	I-NP
O	709	710	.	.	.	O

O	711	715	Most	Most	JJS	B-NP
O	716	718	of	of	IN	B-PP
O	719	722	the	the	DT	B-NP
B-Cancer	723	728	tumor	tumor	NN	I-NP
O	728	729	-	-	HYPH	B-NP
O	729	740	suppressive	suppressive	JJ	I-NP
O	741	751	properties	property	NNS	I-NP
O	752	754	of	of	IN	B-PP
O	755	759	Pten	Pten	NN	B-NP
O	760	763	are	be	VBP	B-VP
O	764	773	dependent	dependent	JJ	B-ADJP
O	774	776	on	on	IN	B-PP
O	777	780	its	its	PRP$	B-NP
O	781	786	lipid	lipid	NN	I-NP
O	787	798	phosphatase	phosphatase	NN	I-NP
O	799	807	activity	activity	NN	I-NP
O	807	808	,	,	,	O
O	809	814	which	which	WDT	B-NP
O	815	823	inhibits	inhibit	VBZ	B-VP
O	824	827	the	the	DT	B-NP
O	828	848	phosphatidylinositol	phosphatidylinositol	NN	I-NP
O	848	849	-	-	HYPH	B-NP
O	849	850	3	3	CD	I-NP
O	850	851	'	'	SYM	I-NP
O	851	852	-	-	HYPH	I-NP
O	852	858	kinase	kinase	NN	I-NP
O	859	860	(	(	(	O
O	860	864	PI3K	PI3K	NN	B-NP
O	864	865	)	)	)	O
O	865	866	/	/	SYM	B-NP
O	866	869	Akt	Akt	NN	I-NP
O	870	879	signaling	signaling	NN	I-NP
O	880	887	pathway	pathway	NN	I-NP
O	888	895	through	through	IN	B-PP
O	896	913	dephosphorylation	dephosphorylation	NN	B-NP
O	914	916	of	of	IN	B-PP
O	917	937	phosphatidylinositol	phosphatidylinositol	NN	B-NP
O	937	938	-	-	HYPH	B-NP
O	938	939	(	(	(	I-NP
O	939	940	3	3	CD	I-NP
O	940	941	,	,	,	I-NP
O	941	942	4	4	CD	I-NP
O	942	943	,	,	,	I-NP
O	943	944	5	5	CD	I-NP
O	944	945	)	)	)	O
O	945	946	-	-	HYPH	B-NP
O	946	958	triphosphate	triphosphate	NN	I-NP
O	958	959	.	.	.	O

O	960	963	The	The	DT	B-NP
O	964	974	additional	additional	JJ	I-NP
O	975	983	function	function	NN	I-NP
O	984	986	of	of	IN	B-PP
O	987	991	Pten	Pten	NN	B-NP
O	992	994	as	as	IN	B-PP
O	995	996	a	a	DT	B-NP
O	997	1001	dual	dual	JJ	I-NP
O	1001	1002	-	-	HYPH	I-NP
O	1002	1013	specificity	specificity	NN	I-NP
O	1014	1021	protein	protein	NN	I-NP
O	1022	1033	phosphatase	phosphatase	NN	I-NP
O	1034	1037	may	may	MD	B-VP
O	1038	1042	also	also	RB	I-VP
O	1043	1047	play	play	VB	I-VP
O	1048	1049	a	a	DT	B-NP
O	1050	1054	role	role	NN	I-NP
O	1055	1057	in	in	IN	B-PP
B-Cancer	1058	1064	glioma	glioma	NN	B-NP
O	1065	1077	pathogenesis	pathogenesis	NN	I-NP
O	1077	1078	.	.	.	O

O	1079	1086	Besides	Besides	IN	B-PP
O	1087	1090	the	the	DT	B-NP
O	1091	1097	wealth	wealth	NN	I-NP
O	1098	1100	of	of	IN	B-PP
O	1101	1105	data	datum	NNS	B-NP
O	1106	1117	elucidating	elucidate	VBG	B-VP
O	1118	1121	the	the	DT	B-NP
O	1122	1132	functional	functional	JJ	I-NP
O	1133	1138	roles	role	NNS	I-NP
O	1139	1141	of	of	IN	B-PP
O	1142	1146	Pten	Pten	NNP	B-NP
O	1146	1147	,	,	,	O
O	1148	1154	recent	recent	JJ	B-NP
O	1155	1162	studies	study	NNS	I-NP
O	1163	1170	suggest	suggest	VBP	B-VP
O	1171	1172	a	a	DT	B-NP
O	1173	1183	diagnostic	diagnostic	JJ	I-NP
O	1184	1196	significance	significance	NN	I-NP
O	1197	1199	of	of	IN	B-PP
O	1200	1204	PTEN	PTEN	NN	B-NP
O	1205	1209	gene	gene	NN	I-NP
O	1210	1221	alterations	alteration	NNS	I-NP
O	1222	1224	as	as	IN	B-PP
O	1225	1226	a	a	DT	B-NP
O	1227	1236	molecular	molecular	JJ	I-NP
O	1237	1243	marker	marker	NN	I-NP
O	1244	1247	for	for	IN	B-PP
O	1248	1252	poor	poor	JJ	B-NP
O	1253	1262	prognosis	prognosis	NN	I-NP
O	1263	1265	in	in	IN	B-PP
B-Cancer	1266	1276	anaplastic	anaplastic	JJ	B-NP
I-Cancer	1277	1289	astrocytomas	astrocytoma	NNS	I-NP
O	1290	1293	and	and	CC	O
B-Cancer	1294	1304	anaplastic	anaplastic	JJ	B-NP
I-Cancer	1305	1323	oligodendrogliomas	oligodendroglioma	NNS	I-NP
O	1323	1324	.	.	.	O

O	1325	1336	Furthermore	Furthermore	RB	B-ADVP
O	1336	1337	,	,	,	O
O	1338	1341	the	the	DT	B-NP
O	1342	1353	possibility	possibility	NN	I-NP
O	1354	1356	of	of	IN	B-PP
O	1357	1366	selective	selective	JJ	B-NP
O	1367	1376	targeting	targeting	NN	I-NP
O	1377	1379	of	of	IN	B-PP
B-Cell	1380	1384	PTEN	PTEN	NN	B-NP
I-Cell	1385	1391	mutant	mutant	JJ	I-NP
I-Cell	1392	1397	tumor	tumor	NN	I-NP
I-Cell	1398	1403	cells	cell	NNS	I-NP
O	1404	1406	by	by	IN	B-PP
O	1407	1415	specific	specific	JJ	B-NP
O	1416	1429	pharmacologic	pharmacologic	JJ	I-NP
O	1430	1440	inhibitors	inhibitor	NNS	I-NP
O	1441	1443	of	of	IN	B-PP
O	1444	1451	members	member	NNS	B-NP
O	1452	1454	of	of	IN	B-PP
O	1455	1458	the	the	DT	B-NP
O	1459	1463	Pten	Pten	NN	I-NP
O	1463	1464	/	/	SYM	B-NP
O	1464	1468	PI3K	PI3K	NN	I-NP
O	1468	1469	/	/	SYM	I-NP
O	1469	1472	Akt	Akt	NN	I-NP
O	1473	1480	pathway	pathway	NN	I-NP
O	1481	1486	opens	open	VBZ	B-VP
O	1487	1489	up	up	RP	B-PRT
O	1490	1493	new	new	JJ	B-NP
O	1494	1506	perspectives	perspective	NNS	I-NP
O	1507	1510	for	for	IN	B-PP
O	1511	1512	a	a	DT	B-NP
O	1513	1521	targeted	target	VBN	I-NP
O	1522	1531	molecular	molecular	JJ	I-NP
O	1532	1539	therapy	therapy	NN	I-NP
O	1540	1542	of	of	IN	B-PP
B-Cancer	1543	1552	malignant	malignant	JJ	B-NP
I-Cancer	1553	1560	gliomas	glioma	NNS	I-NP
O	1560	1561	.	.	.	O

